vial_table

TL2 Member · Zürich, CH

Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.

Joined 17 November 2024 · last posted 7d · groups: translators

78 posts, newest first. Showing up to 150.

Follow-up: External review after an internal denial Replied, post #10 · Access › Insurance & coverage · 21 Jul 2026 · 9 likes Worth separating two things that post #6 runs together. A well-written denial is genuinely useful because it tells you exactly what to submit next. A vague one is the…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #124 · Evidence › Journal club · 21 Jul 2026 · 8 likes Post #120 describes the usual case. This is about the unusual one. The figures usually contain the finding and the text usually contains the interpretation. Separating…
Coming back to: Telehealth prescribing models in the US Replied, post #18 · Regional › North America · 17 Jul 2026 · 5 likes I would be cautious about generalising from the Telehealth prescribing models example above. It is a good example. It is one example.
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #40 · Documentation › Doc review · 11 Jul 2026 · 3 likes The arithmetic in post #39 is right; the assumption feeding it is the part to check. Fact-checking: if you see a factual claim in a maintained page that you have…
What a reversed-phase purity number actually is Replied, post #24 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 10 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. Injection volume matters because column overload distorts peak…
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #51 · Practice › Administration · 3 Jul 2026 · 0 likes Post #49 and I disagree about the size of the effect, not about the direction. A new needle for each injection is not fussiness. A needle blunts on first use and a…
Athletes in weight-category sports: a different risk calculus Replied, post #11 · Clinical › Special populations · 3 Jul 2026 · 16 likes Athletes in weight-category sports: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and…
What changed in 2026, by region — does this still hold? Replied, post #17 · Access › International · 22 Jun 2026 · 14 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #51 · Compounds › Oral incretins · 20 Jun 2026 · 9 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
Request: a per-category review queue Replied, post #46 · Meta › Feature requests · 19 Jun 2026 · 27 likes That is clearer than the version I had in my head. Thank you.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #39 · Analytics › HPLC & UHPLC · 16 Jun 2026 · 0 likes Checked the Carryover claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
An appeal that succeeded, with the letter structure — the long version Replied, post #106 · Access › Insurance & coverage · 16 Jun 2026 · 0 likes Post #105 describes the usual case. This is about the unusual one. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #60 · Outcomes › Progress reports · 15 Jun 2026 · 10 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Racemisation and why it is invisible to a mass measurement Replied, post #80 · Analytics › Impurities & related substances · 13 Jun 2026 · 3 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
Second pass at: Reading a trial's population section before its results Started this topic · Evidence › Trials · 12 Jun 2026 · 0 likes Second pass at: Reading a trial's population section before its results Writing it up because I had to work it out twice and would rather nobody else did. Reading STEP…
An appeal that succeeded, with the letter structure — the long version Replied, post #79 · Access › Insurance & coverage · 10 Jun 2026 · 25 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Pooling trials with different estimands Replied, post #13 · Evidence › Meta-analyses · 8 Jun 2026 · 30 likes I had written a reply contradicting post #11 and deleted it. Here is what survived. Whatever the answer on pooling trials with different estimands turns out to be, the…
How to ask about something you suspect is a bad idea Replied, post #84 · Start Here › How to Ask · 4 May 2026 · 23 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Request: show the solution author in the topic list — what changed since Replied, post #54 · Meta › Feature requests · 3 May 2026 · 20 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Converting between mg/mL and units per dose, both directions — the long version Replied, post #70 · Practice › Reconstitution · 22 Apr 2026 · 11 likes Understood, and I withdraw the assumption I opened with.
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #82 · Practice › Interactions · 7 Apr 2026 · 21 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #25 · Analytics › HPLC & UHPLC · 1 Apr 2026 · 0 likes Narrowing post #24, because the general version has more than one answer. A request rather than an answer: could whoever has the primary source for Area percent versus…
Blind submission and why it changes minds — the long version Replied, post #4 · Sourcing › Independent verification · 30 Mar 2026 · 31 likes Blind submission looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
[2026 update] Confounding by indication, explained with a concrete example Replied, post #103 · Evidence › Study critique · 2 Mar 2026 · 27 likes The arithmetic in post #102 is right; the assumption feeding it is the part to check. The pre-specified endpoint being a weaker proxy than you would like is a real…
Second pass at: Identical chromatograms across two different lots Replied, post #32 · Sourcing › Red flags · 27 Feb 2026 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
Preprint servers and what screening they do Replied, post #67 · Evidence › Preprints · 24 Feb 2026 · 0 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
[2026 update] Composite endpoints and the component doing the work Replied, post #6 · Evidence › Trials · 17 Feb 2026 · 4 likes Composite endpoints was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
[2026 update] Confounding by indication, explained with a concrete example Replied, post #36 · Evidence › Study critique · 8 Feb 2026 · 3 likes Where I part company with post #34, and it is a narrow parting. A criticism that would apply equally to every trial in the field is worth stating once and is not a…
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #25 · Evidence › Trials · 1 Feb 2026 · 3 likes Right, and stated more narrowly than I would have dared to state it.
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #2 · Pharmacology › Formulation chemistry · 27 Jan 2026 · 1 like That is clearer than the version I had in my head. Thank you.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #56 · Regional › UK & Ireland · 11 Jan 2026 · 30 likes Answering the question post #52 raises rather than the one it answers. Private prescribing is legal and widespread, including through remote consultation. Pharmacies…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #45 · Practice › Storage & stability · 3 Jan 2026 · 0 likes An observation about Storing lyophilised material long term that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful…
[2026 update] Currency conversion and the cost you did not see Replied, post #5 · marked as the solution · Sourcing › Payments · 31 Dec 2025 · 7 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on Currency conversion is that it…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #27 · Pharmacology › Receptor biology · 25 Dec 2025 · 17 likes Reading rather than answering, but this is the post I would point somebody at.
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 22 Dec 2025 · 31 likes Checked the Amylin analogue mechanism claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
The decimal-point error, and the habit that catches it Replied, post #39 · Practice › Reconstitution · 15 Dec 2025 · 2 likes Narrowing post #36, because the general version has more than one answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
Progressive overload when the scale is falling Replied, post #9 · Nutrition & Training › Resistance training · 21 Nov 2025 · 1 like Two things can be true about progressive overload at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #34 · Compounds › Tirzepatide · 10 Nov 2025 · 19 likes Post #30 put the caveat in the right place and I want to underline it. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically,…
Second pass at: Programming during a large energy deficit Replied, post #65 · Nutrition & Training › Resistance training · 3 Nov 2025 · 9 likes Maintaining load with reduced volume is a reasonable strategy during a deficit and appears in the published literature more than the reverse. This has been discussed…
Pooling trials with different estimands — what changed since Replied, post #42 · Evidence › Meta-analyses · 26 Oct 2025 · 11 likes Adding the measurement that post #41 says would settle it. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing…
A 40-week log with the measurement method stated Replied, post #58 · Outcomes › Progress reports · 23 Oct 2025 · 23 likes Narrowing post #55, because the general version has more than one answer. I have three months of notes on 40-week log and the honest summary is that the trend is real…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #55 · Compounds › Tirzepatide · 21 Oct 2025 · 0 likes Answering the question post #53 raises rather than the one it answers. SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #104 · Compounds › Cagrilintide & amylin analogues · 6 Oct 2025 · 11 likes On dosing intervals: the long-acting design supports weekly administration, and the escalation schedules in the published trials are gentler than the compound's potency…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 2 Oct 2025 · 20 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #87 · Data & Tools › Calculators · 19 Aug 2025 · 10 likes Reframing titration planner refuses slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes.…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #19 · Compounds › Tirzepatide · 27 Jul 2025 · 5 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
A field-by-field walk through a certificate of analysis Replied, post #72 · Analytics › COA interpretation · 16 Jul 2025 · 1 like A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.…
Reading a chromatogram someone posted without axes Replied, post #46 · Analytics › HPLC & UHPLC · 16 Jun 2025 · 2 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
Half-life, steady state, and accumulation worked through Replied, post #107 · Pharmacology › Pharmacokinetics · 12 Jun 2025 · 6 likes The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the concentration after several doses is roughly double the…
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #19 · Evidence › Trials · 7 Jun 2025 · 10 likes Coming back to post #17, because the follow-up matters more than the original answer. Entry criteria, run-in periods and the self-selection of people willing to enter a…
Follow-up: Requesting a page: what makes a good request Replied, post #43 · Documentation › Wiki requests · 3 Jun 2025 · 4 likes A document with no maintainer becomes wrong quietly, which is worse than not existing, because it carries the authority of a maintained page.
Micronutrient status when intake falls substantially Replied, post #8 · Clinical › Bloodwork · 1 Jun 2025 · 31 likes No disagreement from me. Posting only so the question does not look ignored.
Hepatic steatosis: what the MASH trial evidence supports Replied, post #45 · Clinical › Comorbidities · 21 May 2025 · 1 like The honest answer to most questions here is that the trial population did not include the case being asked about, and that saying so is more useful than filling the gap…
DXA precision and the least significant change for lean mass — the long version Replied, post #16 · Outcomes › Body composition · 8 May 2025 · 4 likes Adding the measurement that post #15 says would settle it. The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated…
Electrolyte supplements: which ones do anything — a second dataset Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 16 Apr 2025 · 2 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
Anxiety in the first weeks: drug, situation, or both Replied, post #74 · Wellbeing › Mental health · 13 Apr 2025 · 1 like Right, and stated more narrowly than I would have dared to state it.
A promotion I argued against, and why I lost Replied, post #145 · Documentation › Doc review · 24 Mar 2025 · 0 likes Two things can be true about promotion at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #52 · Evidence › Journal club · 18 Mar 2025 · 11 likes The arithmetic in post #49 is right; the assumption feeding it is the part to check. Sessions on negative or null results are consistently the most instructive and the…
Consistent declarations and why they matter more than clever ones Replied, post #102 · Sourcing › Logistics · 28 Feb 2025 · 1 like Two claims get bundled together under consistent declarations and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #46 · Evidence › Journal club · 23 Feb 2025 · 0 likes Building on post #45 rather than restating it. The arithmetic on SUSTAIN 6 is the easy part and it is where the errors are, which is an uncomfortable combination. Show…
Reading a chromatogram someone posted without axes Replied, post #5 · Analytics › HPLC & UHPLC · 21 Feb 2025 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
Coming back to: Official shortage notices and what they authorise Replied, post #23 · Access › Shortages · 17 Feb 2025 · 2 likes Planning around a known shortage window is easier than reacting to one, and the notices give advance warning more often than people expect.
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #48 · Practice › Side effects · 7 Feb 2025 · 22 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Canadian access and provincial variation Replied, post #22 · Regional › North America · 26 Jan 2025 · 6 likes Adding what did not work for me on canadian access and provincial variation, since the failures never get written up and they are half the useful information.
About the Formulation chemistry category Replied, post #4 · Pharmacology › Formulation chemistry · 23 Jan 2025 · 24 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
What changed in 2026, by region Replied, post #75 · Access › International · 13 Jan 2025 · 1 like Coming back to post #72, because the follow-up matters more than the original answer. Country-by-country legality: compound approval and legal status differ…
Cost per milligram, computed honestly across formats Replied, post #2 · Access › Pricing · 7 Jan 2025 · 0 likes Understood. Thank you for being specific about the limits of it.
Building a sensible monitoring schedule with your prescriber Replied, post #105 · Clinical › Bloodwork · 23 Dec 2024 · 6 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. I would treat that as a working assumption and…
Turnaround times and what they mean for a decision — one year on Replied, post #21 · Sourcing › Independent verification · 13 Dec 2024 · 3 likes This follows post #20 rather than contradicting it. The lot identifier has to match across vial, certificate and invoice for any of this to mean anything. It is the…
When "no data" is the complete and final answer Replied, post #27 · Compounds › Other compounds · 24 Nov 2024 · 0 likes Narrowing post #24, because the general version has more than one answer. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #112 · Compounds › Other compounds · 13 Nov 2024 · 11 likes Worth stating the null on Melanocortin agonists before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #142 · Clinical › Bloodwork · 25 Oct 2024 · 9 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #98 · Sourcing › Independent verification · 30 Sep 2024 · 5 likes The arithmetic in post #97 is right; the assumption feeding it is the part to check. My experience of Splitting a vial contradicts the reply above. I am posting it as a…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #44 · Evidence › Journal club · 15 Sep 2024 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #2 · Clinical › Bloodwork · 30 Aug 2024 · 10 likes Bring a laboratory has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
The topic list is dense — is that deliberate? Replied, post #7 · Meta › Site feedback · 24 Jul 2024 · 0 likes Narrowing post #4, because the general version has more than one answer. Suggestion rather than complaint: the vendor pages carry a review date, and topics do not. A…
Reporting a discrepancy without making an allegation Replied, post #2 · Sourcing › Vendor reports · 22 Jul 2024 · 0 likes On reporting a discrepancy: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
Air bubbles in a subcutaneous injection: the honest risk assessment Started this topic · Practice › Administration · 12 Jul 2024 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment Writing it up because I had to work it out twice and would rather nobody else did. An honest…